Company news

Share this article:

Mylan announced that it has completed its acquisition of Merck KGaA's generics business. Mylan and Merck KGaA initially announced the signing of a definitive agreement under which Mylan would acquire Merck Generics for $6.8 billion in an all-cash transaction on May 12.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M inVISION